CDMO Samsung Biologics Outlines Sustainability Goals and Achievements in Its 2022 ESG Report
On July 11, Samsung Biologics, a leading contract development and manufacturing organization (CDMO), released its second annual environmental, social, and governance (ESG) report. The report, which covers Samsung Biologics’ activities from January to December 2021, outlines the CDMO’s emphasis on sustainability amid substantial growth. The report details Samsung Biologics’ involvement in several global initiatives focused … Read more